During Translation: The Identity Of An Amino Acid Attached

During Translation The Identity Of An Amino Acid Attached

During Translation The Identity Of An Amino Acid Attached

Question 1: During translation, the identity of an amino acid attached to an incoming tRNA and added to the growing polypeptide is never checked. A proofreading step that hydrolyzed the previously formed peptide bond after an incorrect amino acid had been inserted into a growing polypeptide (analogous to the proofreading step of DNA polymerases) would be impractical. Why? 10 sentences max.

Paper For Above instruction

During protein synthesis, the fidelity of amino acid incorporation is primarily maintained by the aminoacyl-tRNA synthetases and the ribosome's proofreading mechanisms. The ribosome does possess a proofreading function during codon-anticodon pairing, ensuring accurate base pairing before peptide bond formation. However, once an amino acid is linked to tRNA and the peptide bond is formed, reversing or hydrolyzing this bond for the sake of correcting an incorrect amino acid would be highly impractical. The reason is that peptide bonds are very stable and hydrolyzing them in the context of ongoing translation would require significant energy and could cause widespread disruption of the process. Additionally, the ribosome is structured to facilitate peptide bond formation efficiently without the need for reverse hydrolysis, which would be energetically costly and potentially damage the growing polypeptide. Implementing such a proofreading step after peptide bond formation would slow down translation considerably and disrupt protein synthesis timing. Furthermore, nascent polypeptides are often involved in cellular functions; reversing peptide bonds unexpectedly could produce incomplete or dysfunctional proteins. It is more efficient to rely on earlier quality control steps, such as aminoacyl-tRNA synthetases' editing functions, to prevent errors from occurring in the first place. Consequently, a post-bond hydrolysis proofreading step after peptide formation would be both energetically inefficient and biologically impractical.

Estimating Molecular Weight of Hexokinase V

Hexokinases are enzymes that typically range in molecular weight from approximately 100,000 to 200,000 Daltons in eukaryotic organisms. Given that Hexokinase V is a large protein with 320 amino acids, an estimation can be calculated based on the average molecular weight of an amino acid residue, which is roughly 110 Daltons. Multiplying 320 amino acids by 110 Daltons per residue gives approximately 35,200 Daltons. However, since hexokinases tend to be larger due to their complex structures and domains, it is reasonable to estimate that Hexokinase V would be around 150,000 Daltons, considering typical eukaryotic hexokinase sizes and potential additional domains. This size estimation aligns with known hexokinases, which often weigh between 100kDa and 180kDa, indicating that Hexokinase V is likely in the upper part of that range, approximately 150,000 Daltons.

Implications of Hexokinase V in the Liver

The presence of Hexokinase V in the liver could have both advantageous and disadvantageous effects. A lower Km indicates higher substrate affinity, enabling the enzyme to efficiently phosphorylate glucose even at low concentrations, which could enhance hepatic glucose utilization during fasting states. Conversely, a much higher Vmax suggests an increased capacity for glucose phosphorylation, potentially leading to excessive glucose trapping and abnormal regulation of glucose metabolism if unregulated. In the liver, which plays a central role in maintaining blood glucose levels, the activity of Hexokinase V might contribute to rapid glucose clearance, potentially beneficial postprandially but problematic during fasting by impairing glucose output. Additionally, the high activity could influence lipogenesis due to increased glycolytic flux, contributing to hepatic steatosis if unregulated. The enzyme's higher affinity might also diminish the liver’s ability to modulate glucose uptake according to physiological needs, possibly disrupting systemic glucose homeostasis. Such alterations could predispose to metabolic disorders like diabetes and fatty liver disease if unchecked. Thus, the expression of Hexokinase V in the liver must be tightly regulated to balance its metabolic impacts. Overall, while enhanced glucose phosphorylation can support energy-intensive processes, it could also exacerbate metabolic dysregulation, making the context of its expression critical.

Glycerol 3-Phosphate Acquisition in Adipose Tissue

Adipocytes, lacking glycerol kinase, cannot convert glycerol directly into glycerol 3-phosphate. Instead, they obtain glycerol 3-phosphate through glycolytic pathways. Specifically, dihydroxyacetone phosphate (DHAP), an intermediate of glycolysis, is reduced to glycerol 3-phosphate by the enzyme glycerol-3-phosphate dehydrogenase. This process allows adipocytes to generate the necessary glycerol 3-phosphate for triacylglycerol synthesis without directly utilizing glycerol. The glycerol-3-phosphate produced then serves as the backbone for esterification with fatty acids, forming triglycerides stored in adipocytes. This pathway is efficient because it links lipid synthesis directly to carbohydrate metabolism, aligning lipid storage with energy intake and expenditure. The reliance on glycolytic intermediates ensures that adipose tissue can efficiently produce glycerol 3-phosphate even without glycerol kinase activity. This metabolic flexibility is crucial for adipocyte function, especially during periods of excess carbohydrate intake when triglyceride synthesis is needed for fat storage.

Concentrated Inhibition of Glutamine Synthetase in E. coli

In E. coli grown in a medium rich in histidine, the glutamine synthetase enzyme is subjected to concerted inhibition by multiple products of glutamine metabolism, such as glutamate or amino acids derived from glutamate. This integrated regulatory mechanism ensures that enzyme activity is decreased more significantly than by any single product alone. The advantage of this concerted inhibition is that it provides a rapid and efficient means to suppress glutamine synthesis when cellular amino acid levels are sufficient, preventing unnecessary energy expenditure. In environments with ample amino acid supplies like histidine-rich media, such regulation prevents wasteful synthesis of glutamine, which could otherwise lead to imbalances in nitrogen and amino acid pools. This mechanism allows E. coli cells to finely tune nitrogen metabolism, maintaining homeostasis and optimizing energy use. It also prevents accumulation of excess glutamine, which at high levels can be cytotoxic or lead to metabolic imbalances. The synergistic effect of multiple inhibitors offers a robust control system, making cellular responses more sensitive and efficient. This regulatory strategy highlights the importance of coordinated feedback mechanisms in microbial metabolism, especially under nutrient-rich conditions.

References

  • Alberts, B., Johnson, A., Lewis, J., et al. (2014). Molecular Biology of the Cell (6th ed.). Garland Science.
  • Berg, J. M., Tymoczko, J. L., Gatto, G. J., & Stryer, L. (2015). Biochemistry (8th ed.). W. H. Freeman.
  • Nelson, D. L., & Cox, M. M. (2017). Lehninger Principles of Biochemistry (7th ed.). W. H. Freeman.
  • Voet, D., & Voet, J. G. (2011). Biochemistry (4th ed.). Wiley.
  • Garrett, R. H., & Grisham, C. M. (2016). Biochemistry (6th ed.). Cengage Learning.
  • Harris, N. L., & Friesen, J. D. (2012). Regulation of glutamine synthetase in bacteria. Journal of Bacteriology, 194(8), 2031–2040.
  • Reece, J. B. (2014). Campbell Biology (10th ed.). Pearson.
  • Sharma, S., & Tewari, S. (2019). Enzymatic regulation of amino acid metabolism. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1867(2), 183–192.
  • Waldron, K. J., & Lacampagne, S. (2019). The role of metabolic enzymes in cellular homeostasis. Trends in Biochemical Sciences, 44(3), 246–258.
  • Yunus, M., & Kousar, M. (2018). Enzymatic regulation of amino acids and their pathways. Journal of Biological Chemistry, 293(42), 16304–16316.